Status
Conditions
About
The study will include up to 30 AMD patients, recruited by two medical centers, Tel-Aviv medical center and Assuta Hashalom medical center. At the screening visit, the patients will be imaged in their tested, eligible eye(s), using a commercial Zeiss Cirrus or Heidelberg Spectralis OCT.
Full description
Screening visit:
For patients eligible to participate in the study, the following procedure will be done in the "screening visit" at the clinic:
Patient will sign the IC (Informed Consent) form
The following demographic and clinical data will be collected and registered in the CRF:
OCT scanning pattern:
Setup and tutorial home visit:
The device will be delivered to the patient's home with a setup guide attached to the package. The patient will read the setup guide instructions, unpack the device, place it on a table and connect it to a power supply. Upon first usage a tutorial clip, explaining how to operate the device and self-image the eyes, will be automatically displayed on the device's external screen. Following the tutorial patients will be instructed to scan their study eye(s). A remote support service, provided by the sponsor, will be available as needed. Its phone number will be given to the patient and will be attached to the device's base.
Daily home testing:
For each eligible eye, the following procedure will be done in the "Daily testing" at the patients' homes:
Exit visit:
For each eligible eye, the following procedure will be done in the "Exit visit" at the clinic:
OCT scanning pattern:
Macular cube of at least 6X6mm (20 degrees)
At least 40 B-scans per cube NOTAL-OCT V3.0 Scanning.
6.Patient's experience questionnaire
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
NA
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal